AzPA Pharmacy Flash

• COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
  COVID-19 vaccination may enhance the effectiveness of immune checkpoint inhibitors in cancer therapy. A study demonstrated that patients with advanced non-small cell lung cancer or melanoma who received an mRNA COVID-19 vaccine within 100 days of initiating immunotherapy experienced significantly longer survival compared to unvaccinated patients.
• More States Eliminating Insurance Hurdles for Opioid Use Disorder Medications
  A new study reveals that in the last decade, an increasing number of states have streamlined access to life-saving medication for individuals with opioid use disorder.
• FDA Approves Stoboclo and Osenvelt as Biosimilars for Some Cancers
  The U.S. FDA has approved two new biosimilars for Prolia and XGEVA: Stoboclo and Osenvelt, both denosumab-bmwo, for all approved indications.